Lecture abstract:

In my lecture, I will explore evolving approaches to treatment based on my own clinical knowledge, patient survey data, and the emerging scientific literature. I will review the insights, successes, and failures gleaned from seven months of treating patients for COVID spike protein-induced disease in my private practice.

My team and I have largely been guided by an evolving understanding of pathophysiologic mechanisms amidst an ever-increasing knowledge of therapeutic options with favorable mechanisms of action. I will present our current treatment approach, which relies on successive trials of therapy in situations where diagnostic tests often provide limited guidance.

The lecture will conclude with a presentation of the data on the most effective treatments as reported to REACT-19 in their survey of a large sample of long-haul and vaccine-injured patients.

A renowned pulmonologist and critical care specialist, master educator, and clinical researcher, Pierre Kory’s work on COVID-19 has led him to become a world expert in the treatment of all phases of the disease.

The former Chief of the Critical Care Service and Medical Director of the Trauma and Life Support Center at the University of Wisconsin, he is a board-certified specialist in Critical Care Medicine, Pulmonary Diseases, and Internal Medicine.

During the COVID-19 epidemic, Dr. Kory left Wisconsin to lead an ICU in his hometown of New York City during their catastrophic initial surge. Later, he led ICUs in multiple massive outbreak areas, such as Milwaukee and Greenville, S.C.

Since founding FLCCC with Dr. Paul Marik and other colleagues, Dr. Kory testified twice before the U.S. Senate, calling on national healthcare agencies to adopt effective and low-cost therapies such as corticosteroids and ivermectin in response to the pandemic.

He is considered one of the world’s pioneers in the use of ultrasound in the diagnosis and treatment of critically ill patients and was a trailblazer in the United States in the research, development, and teaching of therapeutic hypothermia to treat post-cardiac arrest patients.